HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mangalam, A. Articles by David, C. Search for Related Content PubMed PubMed Citation Articles by Mangalam, A. Articles by David, C.

HLA-DQ8 (DQB1*0302)-Restricted Th17 Cells Exacerbate Experimental Autoimmune Encephalomyelitis in HLA-DR3-Transgenic Mice ¹

Ashutosh Mangalam^*, David Luckey^*, Eati Basal^*, Megan Jackson^2,*, Michele Smart^*, Moses Rodriguez^*, and Chella David^3,*

^* Department of Immunology and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN 55905

Among all of the genetic factors associated with multiple sclerosis (MS) susceptibility, MHC class II molecules have the strongest association. Although a direct role of DR alleles in MS have been confirmed, it has been difficult to understand the role of DQ alleles in disease pathogenesis due to strong linkage disequilibrium with certain DR alleles. Population studies have indicated that DQ alleles may play a modulatory role in progression of MS. Using HLA class II transgenic (Tg) mice, we investigated gene complementation between DR and DQ genes in the disease process. Previously, using single Tg mice (expressing HLA-DR or DQ gene), we showed that PLP_91–110 peptide induced experimental autoimmune encephalomyelitis (EAE) only in DR3.Aβ° mice, suggesting that DR3 (DRB1*0301) is a disease susceptibility gene in the context of PLP. We also showed that DQ6 protects development of EAE in DQ6/DR3 double Tg mice by production of anti-inflammatory IFN-. In this study, we investigated the ability of DQ8 to modulate disease in DR3/DQ8 double Tg mice. Introduction of DQ8 onto DR3 Tg mice led to higher disease incidence and increased disease severity on immunization with PLP_91–110, indicating that DQ8 had an exacerbating effect on the development of EAE. Increased susceptibility in DR3/DQ8 Tg mice was due to increased production of proinflammatory cytokine IL-17 by DQ8-restricted T cells. HLA-DR3/DQ8 mice with EAE also demonstrated increased inflammation and demyelination in CNS as compared with single DR3 Tg mice. Thus double Tg mouse provides a novel model to study epistatic interactions between HLA class II molecules in inflammatory and demyelinating disease.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This work was supported by grants from the National Institutes of Health (NS 0521732, NS24180, and NS32149) and the National Multiple Sclerosis Society (CA1011-03 and RG3172).

² Summer student from Berea College, Berea, KY.

³ Address correspondence and reprint requests to Dr. Chella David, Department of Immunology, Mayo Clinic College of Medicine, 200, 1st Street SW, Rochester, MN 55905. E-mail address: david.chella{at}mayo.edu

⁴ Abbreviations used in this paper: MS, multiple sclerosis; Tg, transgenic; PLP, proteolipid protein; LNC, lymph node cell; MOG, myelin oligodendrocytic glycoprotein; EAE, experimental autoimmune encephalomyelitis; DC, dendritic cell; LN, lymph node; C_t, threshold cycle.